NFE2L2 and cancer: In this research, DENA/AAF-administered rats revealed a noticeable decrease in Nrf2 levels in the lungs; this agrees with the findings of Karin and Dhar [56] and de la Vega et al. [57], who proposed that Nrf2 was linked to the pathogenesis, progression, and metastasis of cancer.